ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 981

Aggregated Genetic Information Explains Variations On Hand Radiographic Scores in Rheumatoid Arthritis Patient

Jing Cui1, Nancy A. Shadick2, Katherine P. Liao3, Michael Weinblatt4, Robert M. Plenge5 and Elizabeth W. Karlson3, 1Rheumatology, Brigham and Women's Hospital, Boston, MA, 2Rheumatology/Immunology, Brigham and Women's Hospital, Boston, MA, 3Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 4Rheumatology & Immunology, Brigham & Women's Hospital, Boston, MA, 5Division of Rheumatology, Immunology and Allergy and Division of Genetics, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: radiography and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Genetics and Genomics of Rheumatic Diseases

Session Type: Abstract Submissions (ACR)

Background/Purpose: Rheumatoid arthritis (RA) has an estimated heritability of approximately 60%. Joint destruction as a severity measure of RA is influenced by genetic factors, however the heritability of this trait remains unclear. Our objective was to determine the genetic heritability of joint destruction, quantified as Sharp/van der Heijde scores (SHS), and to conduct a genome wide association study (GWAS) to identify SNPs associated with quantitative joint damage in RA patients.

Methods: We studied 422 anti-CCP+ RA subjects in a prospective observational RA cohort at an academic hospital with baseline bilateral hand radiographs and blood samples. Using the SHS method, 4 radiologists assigned an erosion score (0-5) for 16 joints, and a joint space narrowing score (0-4) for 15 joints in each hand (total SHS range 0-280). The inter-rater reliability for the SHS in our study was 0.93. SHS measures were normalized by taking the inverse normal of the rank. Samples were genotyped on the Affymetrix 6.0 platform. We applied standard quality control procedures, followed by imputation to 2.5M SNPs using IMPUTE with HapMap2 CEU. Clinical predictors of SHS such as age. gender, disease duration were studied using general linear regression.  We applied mixed linear model analysis to estimate the proportion of variance explained by genotyped SNPs from the whole genome to determine heritability. We studied the association between each SNP and SHS using linear regression assuming a genetic additive model adjusting for the first three principal component values from Eigenvector analysis and RA disease duration.

Results: The 422 RA cases had mean age of 59 yrs, mean disease duration of 17 yrs, and 81% were female. The SHS range was 0-270 with median of 40. Clinical predictors including age and disease duration were significant in univariate analyses, and only disease duration was significant (P <0.0001) in multivariate analyses. Heritability analysis adjusted for disease duration and 3 principal components estimated 22% (p=0.39) of SHS variation was attributable to genetic variants using all genotyped SNP information. From the GWAS, we found 2 SNPs that exceeded the genome-wide significance threshold of 5E-8 (rs16925520 p=4E-9, rs2832760 p=3E-8) for association with SHS. The independent top 10 findings are shown in the table. The MHC region was not significantly associated with SHS. No known RA risk alleles (~50 loci) were associated with SHS.

Conclusion: Our study suggests that joint damage in RA (as measured by SHS) is a heritable trait where genetic factors explain ~22% of the phenotypic variance.  These findings corroborate with a previous study where heritability was estimated to be higher at 45%-58%. Although several SNPs were associated with SHS at genome-wide significance, none were known RA risk alleles.  These findings require confirmation in an independent sample.

Table. Top 10 SNPs associated with Sharp/van der Heijde Hand Score

chr

rs

gene

Base pair

Allele A

Minor allele frequency

beta

P value

9

rs16925520

JMJD2C

7162354

C

0.01

3.52

4.3E-09

21

rs2832760

CLDN8

30584023

G

0.30

0.31

3.3E-08

5

rs10079663

VDAC1

133384433

C

0.41

0.28

1.1E-07

8

rs13256240

–

83633555

A

0.01

-3.38

2.2E-07

9

rs10901313

FUBP3

132275229

C

0.02

-2.13

1.1E-06

4

rs1980037

GYPB

145136964

A

0.02

2.73

1.2E-06

19

rs4801371

ZNF71

61926872

A

0.04

-1.28

1.8E-06

4

rs10024454

IGFBP7

57942964

C

0.32

-0.27

2.2E-06

8

rs1471705

ZFHX4

77880207

A

0.01

-2.79

2.7E-06

1

rs6674099

DISC2

230033485

A

0.45

0.23

3.2E-06


Disclosure:

J. Cui,
None;

N. A. Shadick,

Amgen,

2,

Abbott Immunology Pharmaceuticals,

2,

Genentech and Biogen IDEC Inc.,

2,

Crescendo Bioscience,

2,

Medimmune,

2;

K. P. Liao,
None;

M. Weinblatt,

MedImmune,

2,

Crescendo Bioscience,

2,

MedImmune,

5,

Crescendo Bioscience,

5;

R. M. Plenge,
None;

E. W. Karlson,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/aggregated-genetic-information-explains-variations-on-hand-radiographic-scores-in-rheumatoid-arthritis-patient/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology